Phibro Animal Health Corporation (PAHC)

NASDAQ: PAHC · IEX Real-Time Price · USD
13.29
+0.18 (1.37%)
Sep 30, 2022 4:00 PM EDT - Market closed
1.37%
Market Cap 538.29M
Revenue (ttm) 942.26M
Net Income (ttm) 49.18M
Shares Out 40.50M
EPS (ttm) 1.21
PE Ratio 10.98
Forward PE 14.93
Dividend $0.48 (3.61%)
Ex-Dividend Date Sep 6, 2022
Volume 216,790
Open 13.24
Previous Close 13.11
Day's Range 13.11 - 13.93
52-Week Range 12.71 - 22.96
Beta 0.57
Analysts Sell
Price Target 18.36 (+38.1%)
Earnings Date Oct 31, 2022

About PAHC

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases... [Read more...]

Industry Pharmaceuticals
IPO Date Apr 11, 2014
CEO Jack Bendheim
Employees 1,860
Stock Exchange NASDAQ
Ticker Symbol PAHC
Full Company Profile

Financial Performance

In 2022, PAHC's revenue was $942.26 million, an increase of 13.07% compared to the previous year's $833.35 million. Earnings were $49.18 million, a decrease of -9.58%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for PAHC stock is "Sell." The 12-month stock price forecast is 18.36, which is an increase of 38.15% from the latest price.

Price Target
$18.36
(38.15% upside)
Analyst Consensus: Sell
Stock Forecasts

News

Phibro (PAHC) Down 18.4% Since Last Earnings Report: Can It Rebound?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

1 week ago - Zacks Investment Research

The Carbon Trust Validates Greenhouse Gas Effects of Phibro Feed Additive

BELLA VISTA, Australia--(BUSINESS WIRE)--This spring, Phibro Animal Health introduced RelyOn™ feed additive, a new solution to help support rumen health, animal efficiency and performance. Now, the alte...

1 week ago - Business Wire

Phirbo (PAHC) Faces Rising Costs and Inflationary Pressure

Price competition coming from cheap generic alternatives of a few Phirbo (PAHC) products is a deterrent.

2 weeks ago - Zacks Investment Research

5 Pet Care Stocks Gurus Love

Despite inflationary pressures that are increasing the price of goods across the board, consumers are still pampering their pets when it comes to food.

Other symbols: ELANFRPTIDXXZTS
1 month ago - GuruFocus

Phibro (PAHC) Q4 Earnings Miss Estimates, Sales Surpass

Phibro (PAHC) posts better-than-expected revenues for the fiscal fourth quarter, with robust growth across all segments.

1 month ago - Zacks Investment Research

Phibro Animal Health (PAHC) Q4 Earnings Lag Estimates

Phibro (PAHC) delivered earnings and revenue surprises of -10% and 0.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, a...

1 month ago - Business Wire

Phibro Animal Health Corporation to Participate in Morgan Stanley Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Morgan Stanley Global Healthcare Conference being held at the Sheraton New York....

1 month ago - Business Wire

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2022 Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its fourth quarter and fiscal year 2022 financial results on Wednesday, August 24, 2022, after the mark...

2 months ago - Business Wire

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class...

2 months ago - Business Wire

Here's Why Investors Should Retain Phibro (PAHC) For Now

Investors are optimistic about Phibro's (PAHC) major animal health products and robust vaccine sales.

2 months ago - Zacks Investment Research

Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disea...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) and Rejuvenate Bio, Inc. today announced a collaboration for the development and commercialization of a gene therapy for Mi...

3 months ago - Business Wire

Phibro Issues Inaugural Environmental, Social and Governance Report

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC), a diversified global developer, manufacturer, and supplier of a broad range of animal health and mineral nutrition produc...

3 months ago - Business Wire

Phibro (PAHC) Up 7.6% Since Last Earnings Report: Can It Continue?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

3 months ago - Zacks Investment Research

Phibro (PAHC) Business Hurt by Macro Issues, FX Fluctuations

The increase in raw material costs and freight costs continues to pose challenges for Phibro (PAHC).

3 months ago - Zacks Investment Research

Phibro (PAHC) Q3 Earnings Lag Estimates, 2022 Revenue View Up

In Q3, Phirbo (PAHC) reports growth in the Animal Health business on higher sales of processing aids, which are used to improve production efficiency in the ethanol fermentation industry.

4 months ago - Zacks Investment Research

Phibro Animal Health (PAHC) Q3 Earnings Miss Estimates

Phibro (PAHC) delivered earnings and revenue surprises of -8.33% and 3.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022. Highlights for the three months ended March ...

4 months ago - Business Wire

Here's Why You Should Retain Phibro (PAHC) Stock For Now

Investors are optimistic about Phibro (PAHC) owing to the robust performances by its Animal Health and Mineral Health segments.

5 months ago - Zacks Investment Research

Bet on These 4 Low-Beta, High-Dividend MedTech Stocks for 2022

Stocks like Becton, Dickinson and Company (BDX), Phibro Animal Health (PAHC), McKesson Corporation (MCK) and UnitedHealth Group Inc (UNH) are right picks with strong fundamentals.

Other symbols: BDXMCKUNH
5 months ago - Zacks Investment Research

Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2022 Quarterly Financial Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its third quarter financial results on Wednesday, May 4, 2022, after the market closes. Phibro manageme...

5 months ago - Business Wire

Is Phibro Animal Health (PAHC) a Good Stock for Value Investors?

Let's see if Phibro Animal Health Corporation (PAHC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

6 months ago - Zacks Investment Research

Phibro (PAHC) Rises 6.1% Since Q2 Earnings: What's Driving It?

Investors are optimistic about Phibro's (PAHC) booming vaccine business and strong global presence.

6 months ago - Zacks Investment Research

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

6 months ago - Zacks Investment Research

Here's Why You Should Add Phibro (PAHC) to Your Portfolio Now

Investors are optimistic about Phibro's (PAHC) booming vaccine business and diverse product lines.

6 months ago - Zacks Investment Research